TrialLancet (London, England)2024

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Mehreen S Datoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.